T-CELL LYMPHOMA STAGE IV

This adverse event was reported 57 times

T-CELL LYMPHOMA STAGE IV is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CHLORAMBUCIL 18 0.0046
1 ETOPOSIDE PHOSPHATE 2 0.0012
2 BRENTUXIMAB VEDOTIN 8 0.0008
3 VALGANCICLOVIR 8 0.0004
4 BENDAMUSTINE HYDROCHLORIDE 3 0.0004
5 BENDAMUSTINE HCL 4 0.0003
6 ACITRETIN 1 0.0002
7 MESALAMINE 5 0.0002
8 PERINDOPRIL ERBUMINE 1 0.0002
9 VINCRISTINE SULFATE 5 0.0002
See all drugs enriched for association with T-CELL LYMPHOMA STAGE IV